New Millennium Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.59K Hold
24
﹤0.01% 311
2025
Q3
$1.61K Sell
24
-100
-81% -$7.91K ﹤0.01% 327
2025
Q2
$10.8K Buy
124
+100
+417% +$7.84K 0.01% 192
2025
Q1
$1.64K Hold
24
﹤0.01% 355
2024
Q4
$1.87K Hold
24
﹤0.01% 385
2024
Q3
$1.61K Hold
24
﹤0.01% 311
2024
Q2
$2.72K Buy
+24
New +$3.03K ﹤0.01% 276
2024
Q1
Sell
-100
Closed -$12.4K 158
2023
Q4
$12.4K Hold
100
0.01% 185
2023
Q3
$9.33K Hold
100
0.01% 173
2023
Q2
$12.9K Hold
100
0.01% 161
2023
Q1
$11.6K Hold
100
0.01% 183
2022
Q4
$11.3K Hold
100
0.01% 186
2022
Q3
$8K Sell
100
-4
-4% -$339 0.01% 200
2022
Q2
$8K Buy
+104
New +$9.49K 0.01% 205

Other funds holding DXCM

New Millennium Group's DXCM Position: Q4 2025 in Review

New Millennium Group held its DexCom (DXCM) position steady in Q4 2025 at 24 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #311.

New Millennium Group first reported a position in DXCM in Q2 2022 and has held it in 14 quarters since. The position peaked at $12.9K in Q2 2023. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • New Millennium Group held 24 shares of DexCom worth $1.59K as of Q4 2025.
  • New Millennium Group left its DexCom share count unchanged in Q4 2025.
  • DexCom made up ﹤0.01% of New Millennium Group's portfolio in Q4 2025, its #311 holding.
  • New Millennium Group first reported a position in DexCom in Q2 2022 and has held it in 14 quarters since.
  • New Millennium Group's DexCom position peaked at $12.9K in Q2 2023.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.